{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:22:54Z","timestamp":1772767374970,"version":"3.50.1"},"reference-count":13,"publisher":"Ubiquity Press, Ltd.","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1125044"],"award-info":[{"award-number":["APP1125044"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Balnaves Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["gh"],"DOI":"10.1016\/j.gheart.2019.07.002","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T20:09:50Z","timestamp":1566590990000},"page":"303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Barriers and Facilitators to the Use of Cardiovascular Fixed-Dose\n                        Combination Medication (Polypills) in Andhra Pradesh, India: A Mixed-Methods\n                        Study"],"prefix":"10.5334","volume":"14","author":[{"given":"Abdul","family":"Salam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devarsetty","family":"Praveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anushka","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abha","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3285","published-online":{"date-parts":[[2019,9,1]]},"reference":[{"key":"10.1016\/j.gheart.2019.07.002_bib1","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2019.07.002_bib2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2019.07.002_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2019.07.002_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2019.07.002_bib5","author":"Sabat\u00e9"},{"key":"10.1016\/j.gheart.2019.07.002_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.gheart.2015.04.003","article-title":"Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease","volume":"10","author":"Perel","year":"2015","journal-title":"Glob Heart"},{"key":"10.1016\/j.gheart.2019.07.002_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2015.12.015","article-title":"Effectiveness of fixed dose combination medication (\u201cpolypills\u201d) compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in 6 countries","volume":"205","author":"Webster","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.gheart.2019.07.002_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11886-017-0853-y","article-title":"Strengths and limitations of using the polypill in cardiovascular prevention","volume":"19","author":"Roy","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.gheart.2019.07.002_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(15)00469-9","article-title":"Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data","volume":"387","author":"Khatib","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2019.07.002_bib10","doi-asserted-by":"crossref","first-page":"e002313","DOI":"10.1136\/bmjopen-2012-002313","article-title":"INterpreting the Processes of the UMPIRE Trial (INPUT): protocol for a qualitative process evaluation study of a fixed-dose combination (FDC) strategy to improve adherence to cardiovascular medications","volume":"3","author":"Salam","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.gheart.2019.07.002_bib11","doi-asserted-by":"crossref","first-page":"e008018","DOI":"10.1136\/bmjopen-2015-008018","article-title":"Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease","volume":"5","author":"Wood","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.gheart.2019.07.002_bib12","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(17)30558-5","article-title":"Putting polypills into practice: challenges and lessons learned","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2019.07.002_bib13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/HCO.0b013e3283496759","article-title":"The polypill to prevent cardiovascular disease: physicians\u2019 perspectives","volume":"26","author":"Viera","year":"2011","journal-title":"Curr Opin Cardiol"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816019301139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816019301139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2019.07.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T12:50:15Z","timestamp":1657543815000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/article\/10.1016\/j.gheart.2019.07.002\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2019.07.002","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers and Facilitators to the Use of Cardiovascular Fixed-Dose Combination Medication (Polypills) in Andhra Pradesh, India","name":"articletitle","label":"Article Title"},{"value":"Global Heart","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gheart.2019.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 World Heart Federation (Geneva). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}